球蟲藥物市場報告：2031 年趨勢、預測與競爭分析

未來全球球蟲藥物市場很可能在獸醫診所和零售藥局市場中看到機會。預計全球球蟲藥物市場從 2025 年到 2031 年的複合年成長率為 5.7%。這個市場的主要驅動力是球蟲的上升、獸醫學的發展以及對肉類和家禽產品的需求不斷成長。

• Lucintel 預測，在預測期內，伴同性動物仍將佔據動物類別的很大一部分。
• 在分銷管道類別中，獸醫診所預計在預測期內將經歷最高的成長。
• 根據地區來看，預計北美在預測期內將經歷最高的成長。

球蟲藥物市場的策略性成長機會

由於蛋白質需求增加，全球家禽產量持續增加，球蟲藥物市場預計將顯著成長。這種動態格局為產業相關人員提供了眾多策略機會。配方創新、向永續實踐的轉變以及消費者對動物福利意識的提高正在重塑市場動態。利用這些趨勢可以幫助公司提高市場地位並滿足不斷變化的客戶需求，因此識別和尋求策略成長機會至關重要。

• 拓展新興市場：新興市場的雞肉產量正在上升，具有巨大的成長潛力。公司可以探索東南亞和非洲等地區的夥伴關係和分銷管道，以滿足球蟲藥物日益成長的需求，從而增加其銷售額和市場佔有率。
• 開發新配方：投資研發新配方可以幫助您的產品在擁擠的市場中脫穎而出。透過專注於創新的輸送系統和聯合治療，公司能夠提高療效並減少抗藥性，滿足尋求先進球蟲解決方案的種植者的需求。
• 專注於預防性衛生解決方案：隨著產業向預防性衛生策略轉變，整合到整體控制計畫中的球蟲提供了巨大的機會。開發針對球蟲同時支持整個牛健康的產品將吸引尋求全面解決方案的生產商。
• 與技術提供者合作：與科技公司夥伴關係可以透過資料驅動的洞察力和精密農業技術來增強我們的產品供應。將這些技術整合到您的抗球蟲解決方案中，將能夠提高劑量準確性和羊群監控，最終改善健康並增加銷售。
• 永續產品開發：在產品開發中關注永續性有助於您滿足消費者偏好和監管要求。開發環保的植物來源球蟲藥物不僅能吸引市場興趣，還能使公司成為永續農業的領導者，刺激長期成長。

球蟲藥物市場存在多種策略性成長機會，包括擴展到新興市場、開發新配方、專注於預防性衛生解決方案、與技術提供者合作以及永續產品開發。利用這些手段可以幫助企業提高競爭地位，滿足不斷變化的市場需求，並在這個快速變化的產業中穩固地位。

球蟲藥物市場促進因素與挑戰

由於影響生產實踐和消費者需求的各種因素，球蟲藥物市場正在發生重大轉變。隨著全球家禽消費量的增加，對控制球蟲的有效解決方案的需求也日益增加。然而，市場也面臨監管壓力和消費者偏好變化等挑戰。相關人員必須了解促進因素和挑戰，以應對不斷變化的情況的複雜性並利用成長機會。

推動球蟲藥物市場發展的因素有：

• 增加家禽產量：對家禽產品的需求增加是球蟲藥物市場的主要動力。隨著人口的成長和飲食轉向更高的蛋白質消耗，家禽養殖戶正在尋找有效的解決方案來確保動物健康和生產力，從而導致球蟲藥物的需求增加。
• 提高動物健康意識：動物福利和健康越來越受到消費者和生產者的關注。這種認知正在推動有效球蟲藥物的採用，因為相關人員的目標是保持羊群健康和生產力，同時確保人道的養殖實踐。
• 對替代藥物的監管支持：對牲畜抗生素使用的嚴格監管正在鼓勵替代球蟲的開發。這項變化鼓勵製造商投資符合新準則的創新解決方案，進一步推動市場成長。
• 技術進步：配方和藥物傳輸系統的創新提高了球蟲藥物的有效性。研究開發和技術進步使得能夠最大限度減少抗藥性的產品的開發成為可能，從而對尋求有效治療的種植者俱有吸引力。
• 增加研發投入：對研發的重視程度不斷提高，推動了球蟲藥物市場的創新。公司正在投資研發新的活性成分和聯合治療，不僅是為了滿足當前的需求，也是為了在未來保持競爭力。

球蟲藥物市場面臨的挑戰是：

• 監管挑戰：不斷變化的監管環境給製造商帶來了重大挑戰。遵守嚴格的安全性和有效性標準會減慢產品開發時間、增加成本並使新產品進入市場變得複雜。
• 市場飽和：隨著市場的成長，現有公司之間的競爭加劇，這可能導致市場飽和。這種飽和會壓低價格並擠壓利潤率，使公司更難維持永續成長。
• 消費者偏好的改變：消費者對有機和無抗生素產品的偏好的改變可能會對傳統的球蟲策略提出挑戰。為了滿足這些偏好，生產商需要投資新的適應解決方案。

總之，球蟲藥物市場受到雞肉產量增加、動物健康意識增強、替代品監管支持、技術進步以及研發投資增加的推動。但他們必須應對監管障礙、市場飽和和消費者偏好變化等挑戰。了解這些動態將有助於相關人員應對市場的複雜性並抓住成長機會。

目錄

第1章執行摘要

第2章全球球球蟲藥物市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業驅動力與挑戰

第3章 2019年至2031年市場趨勢及預測分析

• 宏觀經濟趨勢（2019-2024）及預測（2025-2031）
• 全球球蟲藥物市場趨勢（2019-2024）及預測（2025-2031）
• 全球球蟲藥物市場（依動物類型分類）
  • 家畜
  • 寵物
• 全球球蟲藥物市場（依藥物類別分類）
  • 球蟲防治
  • 球蟲
• 全球球蟲藥物市場（依藥物類別分類）
  • 離子載體
  • 抗生素
  • 磺胺類藥物
  • 化學衍生物
  • 其他
• 全球球蟲藥物市場（按分銷管道）
  • 獸醫診所
  • 零售藥局
  • 其他

第4章 2019 年至 2031 年市場趨勢與預測分析 - 按地區

• 全球球蟲藥物市場（按地區）
• 北美球球蟲藥物市場
• 歐洲球球蟲藥物市場
• 亞太地區抗球球蟲藥物市場
• 世界其他地區球蟲藥物市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球球蟲藥物市場的成長機會
  • 全球球蟲藥物市場的成長機會
  • 全球球蟲藥物市場的成長機會（按藥物類別分類）
  • 全球球蟲藥物市場按分銷管道分類的成長機會
  • 按地區：全球球蟲藥物市場的成長機會
• 全球球蟲藥物市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球球蟲藥物市場的產能擴張
  • 全球球蟲藥物市場的合併、收購和合資企業
  • 認證和許可

第7章主要企業簡介

• Zoetis
• Phibro Animal Health Corporation
• Huvepharma
• Elanco
• Biochem Pharma
• Ceva
• Impextraco
• Virbac
• Boehringer Ingelheim International
• MSD Animal Health

The future of the global anticoccidial drug market looks promising with opportunities in the veterinary hospital and retail pharmacy markets. The global anticoccidial drug market is expected to grow with a CAGR of 5.7% from 2025 to 2031. The major drivers for this market are the rising prevalence of coccidiosis, growing developments in veterinary medicine, and expanding demand for meat and poultry products.

• Lucintel forecasts that, within the animal category, companion animals will remain a larger segment over the forecast period.
• Within the distribution channel category, veterinary hospital is expected to witness the highest growth over the forecast period.
• In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Anticoccidial Drug Market

The anticoccidial drug market is evolving rapidly, responding to the growing demand for poultry products and increasing concerns about drug resistance and animal welfare. Innovations in formulations and a shift toward sustainable practices are shaping this market. Regulatory changes and consumer preferences are also driving the development of alternative therapies and natural products. As stakeholders adapt to these challenges, several emerging trends are becoming prominent in the anticoccidial landscape.

• Shift to Natural Products: There is a notable shift toward natural and plant-based anticoccidials as consumers and producers alike seek alternatives to traditional chemical treatments. This trend is fueled by rising awareness of antibiotic resistance and the demand for organic poultry products.
• Innovation in Formulations: The market is witnessing significant innovations in drug formulations, including the development of new delivery systems and combination therapies. These advancements aim to enhance the efficacy of existing products while minimizing the risk of resistance development among coccidia.
• Increased R&D Investment: Pharmaceutical companies are ramping up their research and development efforts to discover novel anticoccidial agents. This trend is driven by the need for more effective solutions and the desire to comply with stricter regulations regarding drug use in livestock.
• Focus on Animal Welfare: Growing awareness of animal welfare issues is prompting producers to adopt more humane farming practices. This shift influences the development of anticoccidials that not only improve health outcomes for poultry but also align with ethical considerations.
• Regulatory Changes: Stricter regulatory frameworks concerning drug usage and safety are emerging globally. These changes compel manufacturers to enhance their product safety profiles and develop more sustainable and effective anticoccidial solutions to meet compliance requirements.

The anticoccidial drug market is undergoing transformative changes characterized by a move toward natural products, innovative formulations, increased research investment, a focus on animal welfare, and evolving regulatory landscapes. These trends not only address current market demands but also pave the way for a more sustainable and effective approach to managing coccidiosis in livestock.

Recent Developments in the Anticoccidial Drug Market

The anticoccidial drug market is evolving in response to growing challenges such as antibiotic resistance, changing consumer preferences, and stricter regulations. Key players are investing in research and development to create more effective and sustainable solutions. As the demand for poultry products increases globally, advancements in formulations and a focus on animal welfare are shaping the landscape. Understanding these recent developments is crucial for stakeholders aiming to navigate the complexities of the market and adapt to emerging trends.

• New Drug Approvals: Recent approvals of novel anticoccidial agents have expanded the market, providing poultry producers with more options to combat coccidiosis. These new products often feature improved efficacy and safety profiles, meeting the demand for alternatives to traditional treatments.
• Enhanced Combination Therapies: The use of combination therapies has gained traction, as they offer synergistic effects against various strains of coccidia. By combining multiple active ingredients, these formulations enhance effectiveness while reducing the likelihood of resistance, making them increasingly popular among producers.
• Focus on Resistance Management: Addressing antibiotic resistance has become a priority in the anticoccidial market. New strategies, such as rotating different classes of anticoccidials and integrating non-pharmaceutical interventions, are being developed to mitigate resistance and maintain treatment efficacy.
• Integration of Technology: Advancements in technology, including precision agriculture and data analytics, are influencing the anticoccidial market. Producers are utilizing these tools to optimize dosing regimens and monitor health outcomes, leading to more efficient use of anticoccidials and better flock management.
• Emphasis on Sustainable Practices: The growing emphasis on sustainability is driving the development of eco-friendly anticoccidials. Companies are increasingly focusing on plant-based formulations and reducing environmental impact, aligning their products with consumer preferences for sustainable and ethically produced food.

The anticoccidial drug market is experiencing significant developments marked by new drug approvals, enhanced combination therapies, a focus on resistance management, the integration of technology, and an emphasis on sustainable practices. These advancements not only respond to current challenges but also position the industry for future growth, ultimately benefiting producers and consumers alike.

Strategic Growth Opportunities for Anticoccidial Drug Market

The anticoccidial drug market is poised for significant growth as global poultry production continues to rise, driven by increasing protein demand. This dynamic landscape presents numerous strategic opportunities for industry players. Innovations in formulations, a shift toward sustainable practices, and growing consumer awareness about animal welfare are reshaping market dynamics. By capitalizing on these trends, companies can enhance their market position and meet evolving customer needs, making it essential to identify and pursue strategic growth opportunities.

• Expansion into Emerging Markets: There is substantial potential for growth in emerging markets where poultry production is on the rise. Companies can explore partnerships and distribution channels in regions like Southeast Asia and Africa to tap into increasing demand for anticoccidial drugs, boosting sales and market share.
• Development of Novel Formulations: Investing in research and development to create novel formulations can differentiate products in a crowded market. By focusing on innovative delivery systems and combination therapies, companies can enhance efficacy and reduce resistance, catering to producers looking for advanced solutions to coccidiosis.
• Focus on Preventive Health Solutions: As the industry shifts toward preventive health strategies, anticoccidial drugs that integrate into holistic management programs present a significant opportunity. Developing products that support overall flock health while targeting coccidiosis can attract producers seeking comprehensive solutions.
• Collaboration with Technology Providers: Forming partnerships with technology firms can enhance product offerings through data-driven insights and precision agriculture techniques. Integrating these technologies into anticoccidial solutions can improve dosing accuracy and flock monitoring, ultimately leading to better health outcomes and increased sales.
• Sustainable Product Development: Emphasizing sustainability in product development can align with consumer preferences and regulatory demands. Creating eco-friendly, plant-based anticoccidials can not only capture market interest but also position companies as leaders in sustainable agriculture, driving long-term growth.

The anticoccidial drug market presents several strategic growth opportunities, including expansion into emerging markets, the development of novel formulations, a focus on preventive health solutions, collaboration with technology providers, and sustainable product development. By pursuing these avenues, companies can enhance their competitive edge, respond to evolving market needs, and secure a robust position in this rapidly changing industry.

Anticoccidial Drug Market Driver and Challenges

The anticoccidial drug market is experiencing significant transformation, driven by various factors that influence production practices and consumer demand. As global poultry consumption rises, the need for effective solutions to combat coccidiosis becomes increasingly critical. However, this market also faces challenges such as regulatory pressures and shifting consumer preferences. Understanding both the drivers and challenges is essential for stakeholders aiming to navigate the complexities of this evolving landscape and capitalize on growth opportunities.

The factors responsible for driving the anticoccidial drug market include:

• Rising Poultry Production: The increasing demand for poultry products is a primary driver of the anticoccidial drug market. As populations grow and diets shift toward higher protein consumption, poultry producers seek effective solutions to ensure animal health and productivity, leading to greater demand for anticoccidials.
• Growing Awareness of Animal Health: There is a heightened focus on animal welfare and health among consumers and producers alike. This awareness drives the adoption of effective anticoccidial drugs, as stakeholders aim to maintain flock health and productivity while ensuring humane farming practices.
• Regulatory Support for Alternatives: Stricter regulations on antibiotic use in livestock are encouraging the development of alternative anticoccidial agents. This shift is prompting manufacturers to invest in innovative solutions that comply with new guidelines, further driving growth in the market.
• Technological Advancements: Innovations in drug formulations and delivery systems are enhancing the efficacy of anticoccidials. Advances in research and technology allow for the development of products that minimize resistance, making them more appealing to producers seeking effective treatments.
• Increased Investment in R&D: The rising focus on research and development is driving innovation in the anticoccidial market. Companies are investing in the discovery of new active ingredients and combination therapies, which not only meet current demands but also position them competitively for the future.

Challenges in the anticoccidial drug market are:

• Regulatory Challenges: The evolving regulatory landscape poses significant challenges for manufacturers. Compliance with stringent safety and efficacy standards can slow down product development timelines and increase costs, complicating market entry for new products.
• Market Saturation: As the market grows, increased competition among existing players can lead to market saturation. This saturation may drive down prices and squeeze profit margins, making it difficult for companies to maintain sustainable growth.
• Consumer Preference Shifts: Changing consumer preferences toward organic and antibiotic-free products can challenge traditional anticoccidial strategies. Producers may need to adapt their practices to meet these preferences, requiring investment in new, compliant solutions.

In conclusion, the anticoccidial drug market is driven by rising poultry production, growing awareness of animal health, regulatory support for alternatives, technological advancements, and increased investment in R&D. However, challenges such as regulatory hurdles, market saturation, and shifting consumer preferences must be addressed. Understanding these dynamics will help stakeholders navigate the complexities of the market and seize growth opportunities.

List of Anticoccidial Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies anticoccidial drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the anticoccidial drug companies profiled in this report include-

• Zoetis
• Phibro Animal Health Corporation
• Huvepharma
• Elanco
• Biochem Pharma
• Ceva
• Impextraco
• Virbac
• Boehringer Ingelheim International
• MSD Animal Health

Anticoccidial Drug by Segment

The study includes a forecast for the global anticoccidial drug market by animal, drug action, drug class, distribution channel, and region.

Anticoccidial Drug Market by Animal [Analysis by Value from 2019 to 2031]:

• Livestock Animals
• Companion Animals

Anticoccidial Drug Market by Drug Action [Analysis by Value from 2019 to 2031]:

• Coccidiostatic
• Coccidiocidal

Anticoccidial Drug Market by Drug Class [Analysis by Value from 2019 to 2031]:

• Ionophore
• Antibiotic
• Sulphonamides
• Chemical Derivative
• Others

Anticoccidial Drug Market by Distribution Channel [Analysis by Value from 2019 to 2031]:

• Veterinary Hospitals
• Retail Pharmacy
• Others

Anticoccidial Drug Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Anticoccidial Drug Market

The anticoccidial drug market is witnessing significant advancements driven by increasing poultry production, rising awareness of animal health, and regulatory changes. Key players are focusing on innovative formulations and alternative therapies to combat drug resistance and improve efficacy. Countries like the United States, China, Germany, India, and Japan are experiencing varied developments influenced by local market demands, regulatory frameworks, and agricultural practices. Understanding these regional dynamics can provide insights into the ultimate trajectory of the global anticoccidial market.

• United States: The U.S. market is seeing a shift toward natural and organic anticoccidials, driven by consumer demand for antibiotic-free poultry. Regulatory bodies are also encouraging alternatives to traditional chemicals to enhance animal welfare.
• China: Rapid growth in poultry farming has prompted Chinese companies to invest in R&D for new anticoccidial agents, focusing on improving efficacy and reducing side effects. Government support for innovative agriculture further boosts these initiatives.
• Germany: In Germany, stringent regulations on antibiotic use are prompting the development of new anticoccidial drugs with lower resistance profiles. Research institutions collaborate with pharmaceutical companies to enhance product safety and effectiveness.
• India: The Indian anticoccidial market is expanding due to increasing poultry consumption and investment in animal health. Local manufacturers are developing cost-effective solutions while also exploring herbal and alternative treatments.
• Japan: The Japanese market is characterized by advanced formulations that aim to reduce environmental impact. The focus on sustainability drives the development of plant-based anticoccidials, aligning with consumer preferences for eco-friendly products.

Features of the Global Anticoccidial Drug Market

Market Size Estimates: Anticoccidial drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Anticoccidial drug market size by various segments, such as by animal, drug action, drug class, distribution channel, and region in terms of value ($B).

Regional Analysis: Anticoccidial drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different animals, drug actions, drug classes, distribution channels, and regions for the anticoccidial drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the anticoccidial drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the anticoccidial drug market by animal (livestock animals and companion animals), drug action (coccidiostatic and coccidiocidal), drug class (ionophore, antibiotic, sulphonamides, chemical derivative, and others), distribution channel (veterinary hospitals, retail pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Anticoccidial Drug Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Anticoccidial Drug Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Anticoccidial Drug Market by Animal
  • 3.3.1: Livestock Animals
  • 3.3.2: Companion Animals
• 3.4: Global Anticoccidial Drug Market by Drug Action
  • 3.4.1: Coccidiostatic
  • 3.4.2: Coccidiocidal
• 3.5: Global Anticoccidial Drug Market by Drug Class
  • 3.5.1: Ionophore
  • 3.5.2: Antibiotic
  • 3.5.3: Sulphonamides
  • 3.5.4: Chemical Derivative
  • 3.5.5: Others
• 3.6: Global Anticoccidial Drug Market by Distribution Channel
  • 3.6.1: Veterinary Hospitals
  • 3.6.2: Retail Pharmacy
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Anticoccidial Drug Market by Region
• 4.2: North American Anticoccidial Drug Market
  • 4.2.1: North American Market by Animal: Livestock Animals and Companion Animals
  • 4.2.2: North American Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others
• 4.3: European Anticoccidial Drug Market
  • 4.3.1: European Market by Animal: Livestock Animals and Companion Animals
  • 4.3.2: European Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others
• 4.4: APAC Anticoccidial Drug Market
  • 4.4.1: APAC Market by Animal: Livestock Animals and Companion Animals
  • 4.4.2: APAC Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others
• 4.5: ROW Anticoccidial Drug Market
  • 4.5.1: ROW Market by Animal: Livestock Animals and Companion Animals
  • 4.5.2: ROW Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Anticoccidial Drug Market by Animal
  • 6.1.2: Growth Opportunities for the Global Anticoccidial Drug Market by Drug Action
  • 6.1.3: Growth Opportunities for the Global Anticoccidial Drug Market by Drug Class
  • 6.1.4: Growth Opportunities for the Global Anticoccidial Drug Market by Distribution Channel
  • 6.1.5: Growth Opportunities for the Global Anticoccidial Drug Market by Region
• 6.2: Emerging Trends in the Global Anticoccidial Drug Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Anticoccidial Drug Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Anticoccidial Drug Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Zoetis
• 7.2: Phibro Animal Health Corporation
• 7.3: Huvepharma
• 7.4: Elanco
• 7.5: Biochem Pharma
• 7.6: Ceva
• 7.7: Impextraco
• 7.8: Virbac
• 7.9: Boehringer Ingelheim International
• 7.10: MSD Animal Health